期刊
EARLY HUMAN DEVELOPMENT
卷 138, 期 -, 页码 -出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.earlhumdev.2019.104844
关键词
Glucose; Hyperglycaemia; Hypoglycaemia; Intensive care; Neonatal; Preterm; Continuous monitoring
资金
- Evelyn Trust
- National Institute of Health Research EME Program
- National Institute of Health Research Cambridge Biomedical Research Centre
Hypoglycaemia and hyperglycaemia are common in infants requiring intensive care and are associated with worse clinical outcomes. However, glucose levels are taken infrequently, and there remains controversy regarding optimal management. In adults and children continuous glucose monitoring (CGM) is now established as an important adjunct to caring for patients at risk from dysglycaemia. This technology is also increasingly providing insights into glucose regulation in the newborn, demonstrating significant periods of clinically silent hypoglycaemia and hyperglycaemia. This baseline data will be important to allow the significance of glucose dysregulation on long-term outcomes to be assessed. Small studies have also shown the potential for CGM to safely support targeting of glucose control in preterm infants, and a large multicentre trial is ongoing. Current technology is not specifically designed for use in NICU, but with rapid technological developments, CGM holds promise for the future care of babies in NICU.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据